In Wednesday’s Wall Street session, Surgepays Inc (NASDAQ:SURG) shares traded at $2.35, up 70.29% from the previous session.
SURG stock price is now 67.00% away from the 50-day moving average and 19.11% away from the 200-day moving average. The market capitalization of the company currently stands at $47.37M.
In other news, Cox Kevin Brian, CEO and Chairman of Board sold 35,180 shares of the company’s stock on Dec 03 ’24. The stock was sold for $64,084 at an average price of $1.82. Upon completion of the transaction, the CEO and Chairman of Board now directly owns 5,770,090 shares in the company, valued at $13.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 02 ’24, Chief Financial Officer Evers Anthony George sold 36,666 shares of the business’s stock. A total of $68,199 was realized by selling the stock at an average price of $1.86. This leaves the insider owning 214,924 shares of the company worth $0.51 million. A total of 30.82% of the company’s stock is owned by insiders.
During the past 12 months, Surgepays Inc has had a low of $1.05 and a high of $4.38. As of last week, the company has a debt-to-equity ratio of 0.30, a current ratio of 2.95, and a quick ratio of 2.66. The fifty day moving average price for SURG is $1.3918 and a two-hundred day moving average price translates $1.9811 for the stock.
The latest earnings results from Surgepays Inc (NASDAQ: SURG) was released for 2024-12-31. The net profit margin was -75.11% and return on equity was -209.93% for SURG. The company reported revenue of $9.6 million for the quarter, compared to $32.32 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -70.3 percent. For the current quarter, analysts expect SURG to generate $9.67M in revenue.
